Biotech Stocks Worth Watching This October 2024
October is shaping up as a critical month for biotech. Here are the names traders should have on their radar right now.
Biotech is one of those sectors where timing is everything. Catalysts hit fast — FDA decisions, trial readouts, earnings surprises — and the stocks move violently in both directions. October historically brings a wave of these events, making it one of the most active months of the year for biotech traders.
The sector has been through a rough stretch. Rising rates squeezed speculative capital, and small-cap biotech names took the worst of it. But rotation is starting to happen. With the Fed signaling rate cuts and risk appetite creeping back, money is looking for beaten-down sectors with upside leverage. Biotech fits that profile.
Read more Trump Rules Out Iran Strike Before November Midterms →
If you're watching biotech right now, the playbook is simple: identify names with near-term catalysts, size appropriately because binary events can go either way, and avoid averaging down into broken charts. The reward-to-risk on well-timed biotech plays can be exceptional — but only if you respect the downside.
The original watchlist from Daily Political's Stacy Sanders covers specific names worth tracking heading into this month's key events. Getting the actual ticker-by-ticker breakdown requires access to the full report.
Continue reading at dailypolitical (stacy sanders)
